Scientists probe Kids' brain tumors for genetic clues and drug weaknesses
NCT ID NCT07417072
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to better understand pediatric brain tumors by analyzing tumor and blood samples from 50 children aged 3-18. Researchers will use advanced genetic tests and create 3D tumor models in the lab to see how different chemotherapy drugs affect the cells. The goal is to uncover why some tumors resist treatment and to pave the way for more personalized therapies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC BRAIN TUMORS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Meyer Children's Hospital IRCCS
RECRUITINGFlorence, Firenze, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••